BioXcel Therapeutics Inc.
0.34
-0.02 (-4.68%)
At close: Jan 15, 2025, 12:48 PM

BioXcel Therapeutics Inc. Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for BTAI stock have an median target of 3, with a low estimate of 0.25 and a high estimate of 5. The median target predicts an increase of 782.35% from the current stock price of 0.34.

Analyst Consensus: Buy
Target Low Average Median High
Price $0.25 $2.81 $3 $5
Change -26.47% 726.47% 782.35% 1370.59%

AI Analyst Report

HC Wainwright & Co. reaffirms a Buy rating on BioX... Unlock content with Pro Subscription

Updated Oct 21, 2024

Rating May 24Jun 24Aug 24Sep 24Oct 24Jan 25
Strong Buy 000000
Buy 112111
Hold 001000
Sell 000001
Strong Sell 000000
Total 1 1 3 1 1 2

Financial Forecast this Year

Revenue This Year
2.73M
from 1.38M
Increased by 97.8%
Revenue Next Year
5.99M
from 2.73M
Increased by 119.6%
EPS This Year
-1.71
from -6.15
Increased by 72.2%
EPS Next Year
-1.33
from -1.71
Increased by 22.2%